Glaukos Corporation (NYSE: GKOS) kicked off on Tuesday, down -4.42% from the previous trading day, before settling in for the closing price of $86.07. Over the past 52 weeks, GKOS has traded in a range of $77.91-$163.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 10.99% over the past five years. While this was happening, its average annual earnings per share was recorded 47.36%. With a float of $54.47 million, this company’s outstanding shares have now reached $56.44 million.
Let’s look at the performance matrix of the company that is accounted for 995 employees. In terms of profitability, gross margin is 75.48%, operating margin of -28.2%, and the pretax margin is -37.97%.
Glaukos Corporation (GKOS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Glaukos Corporation is 3.71%, while institutional ownership is 101.28%. The most recent insider transaction that took place on Mar 25 ’25, was worth 162,399. In this transaction SVP & CHIEF FINANCIAL OFFICER of this company sold 1,520 shares at a rate of $106.84, taking the stock ownership to the 53,431 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Officer proposed sale 1,520 for $106.84, making the entire transaction worth $162,402.
Glaukos Corporation (GKOS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.36% per share during the next fiscal year.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
Take a look at Glaukos Corporation’s (GKOS) current performance indicators. Last quarter, stock had a quick ratio of 5.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Glaukos Corporation (NYSE: GKOS) saw its 5-day average volume 1.58 million, a positive change from its year-to-date volume of 0.89 million. As of the previous 9 days, the stock’s Stochastic %D was 20.94%. Additionally, its Average True Range was 6.86.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 5.08%, which indicates a significant decrease from 14.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.97% in the past 14 days, which was higher than the 60.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $121.02, while its 200-day Moving Average is $130.05. Nevertheless, the first resistance level for the watch stands at $89.20 in the near term. At $96.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $100.51. If the price goes on to break the first support level at $77.90, it is likely to go to the next support level at $73.53. The third support level lies at $66.59 if the price breaches the second support level.
Glaukos Corporation (NYSE: GKOS) Key Stats
The company with the Market Capitalisation of 4.65 billion has total of 56,567K Shares Outstanding. Its annual sales at the moment are 383,480 K in contrast with the sum of -146,370 K annual income. Company’s last quarter sales were recorded 105,500 K and last quarter income was -33,580 K.
